These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 34366151)

  • 1. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
    Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
    Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over.
    Cavillon Decaestecker M; Ferret L; Decaestecker K; Gautier S; Verdun S; Tsogli ES
    Drugs Aging; 2021 Oct; 38(10):939-950. PubMed ID: 34486094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants.
    Abdrakhmanov A; Shaimerdinova A; Suleimen Z; Abildinova S; Albayev R; Tuyakova G; Rib E; Beysenbayeva A; Kabduyeva G; Bekbossynova M
    Ther Adv Cardiovasc Dis; 2024; 18():17539447241249886. PubMed ID: 38801157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
    Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
    J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study.
    Nosáľ V; Petrovičová A; Škorňová I; Bolek T; Dluhá J; Stančiaková L; Sivák Š; Babálová L; Hajaš G; Staško J; Kubisz P; Kurča E; Samoš M; Mokáň M
    Eur J Clin Pharmacol; 2022 Apr; 78(4):557-564. PubMed ID: 35066599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
    Macha K; Marsch A; Siedler G; Breuer L; Strasser EF; Engelhorn T; Schwab S; Kallmünzer B
    Stroke; 2019 Apr; 50(4):873-879. PubMed ID: 30852963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study.
    Aigami T; Ishigo T; Takada R; Yano T; Koyama M; Katano S; Fujii S; Fukudo M
    J Clin Pharmacol; 2023 Jun; 63(6):654-663. PubMed ID: 36609916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in anticoagulant prescribing: a review of local policies in English primary care.
    Ho KH; van Hove M; Leng G
    BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurological perspective in the choice of direct oral anticoagulants for prevention of stroke in atrial fibrillation].
    Ameriso SF; Pujol Lereis VA
    Medicina (B Aires); 2023; 83(2):273-277. PubMed ID: 37094196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF.
    Guenoun M; Cohen S; Villaceque M; Sharareh A; Schwartz J; Hoffman O; Dib JC; Ouazana L; Assouline S; Parrens E; Garban T; Pradeau V; Guedj-Meynier D; Lequeux B; Cohen C; Durand P; Dievart F; Dhanjal TS; Sabouret P; Lellouche N
    Europace; 2023 Oct; 25(10):. PubMed ID: 37801642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review.
    Zhao Y; Guo M; Li D; Xu W; Pan C; He C; Cui X
    Clin Appl Thromb Hemost; 2023; 29():10760296231153638. PubMed ID: 36760080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remaining activity of temporary interrupted direct oral anticoagulants and its impact on intra-ablation heparinization in patients with atrial fibrillation: Comparisons across four drugs and two dose regimens.
    Sairaku A; Onohara Y; Hironobe N; Matsumura H; Kihara Y; Nakano Y
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):1996-2004. PubMed ID: 32459011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.
    Baker CL; Dhamane AD; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Menges B; Lin J; Nadkarni A
    Adv Ther; 2019 Jan; 36(1):162-174. PubMed ID: 30499067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
    Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
    Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory assessment of the direct oral anticoagulants: who can benefit?
    Akpan IJ; Cuker A
    Kardiol Pol; 2021; 79(6):622-630. PubMed ID: 34029374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures.
    Russo V; Caiazza E; Femine FCD; Pezzullo E; Sarpa S; Ianniciello A; Alfredo C; D'Andrea A; Golino P; Nigro G
    Cardiovasc Drugs Ther; 2024 Mar; ():. PubMed ID: 38507041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study.
    Perlman A; Goldstein R; Choshen Cohen L; Hirsh-Raccah B; Hakimian D; Matok I; Kalish Y; Singer DE; Muszkat M
    CNS Drugs; 2021 Mar; 35(3):305-316. PubMed ID: 33595834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.